OBJECTIVE: To determine mortality and immune status improvement in HIV-infected
pediatric patients on antiretroviral treatment (ART) in Malawi, Lesotho, and Swaziland …

Background. There are scarce data on the long-termsurvival of human immunodeficiency
virus (HIV)—infected children receiving antiretroviral therapy (ART) in lower-middle income …

OBJECTIVE: Under Millennium Development Goal 4, countries are required to reduce child
mortality by two-thirds between 1990 and 2015. In countries with generalized epidemics of …

Background: Increasing numbers of HIV-infected children not yet eligible for antiretroviral
therapy (ART) are entering health care in Africa. We sought to characterize the risk of short …

Background Antiretroviral therapy (ART) substantially decreases morbidity and mortality in
people living with HIV. In this study, we describe population-level trends in the adult life …

Recent estimates show that over the past decade there has been a stagnation and reversal
in the previous gains made in child mortality in some countries. HIV/AIDS is thought to be an …

Background In spite of the global decreasing mortality associated with HIV, adolescents
living with HIV (ADLHIV) in sub-Saharan Africa still experience about 50% mortality rate. We …

Background There is limited evidence on the optimal timing of antiretroviral therapy (ART)
initiation in children 2–5 y of age. We conducted a causal modelling analysis using the …

Background Deaths in HIV-positive people have decreased since the introduction of highly
active antiretroviral therapy (HAART) in 1996. Fewer AIDS-related deaths and an ageing …

Objective: To estimate mortality in HIV-positive patients starting combination antiretroviral
therapy (ART) and to discuss different approaches to calculating correction factors to …